By suppressing tumor growth and metastasis through the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway, NCOA7 emerges as a promising prognostic marker and potential therapeutic target for ccRCC [14]. This evidence concerns the gene WNK2 and nonpapillary renal cell carcinoma.